Pharmacy and Wellness Review
Article Title
Abstract
Over the last several years, a noteworthy association between gastrointestinal (GI) disorders and autism spectrum disorders (ASD) has been documented, although no large population-based studies exist. GI disorders in ASD children may stem from the underlying behavioral, communication, sensory or neurological issues intrinsic to the autistic disorder itself; therefore, the incorporation of alternative therapies, including behavioral modification, may be compelling treatment additions to the GI care traditionally recommended in children. To improve GI symptoms and quality of life in ASD children, a multidisciplinary approach is optimal, with pharmacists playing an active role in determining appropriate pharmacotherapy. Although there is a need for additional clinical trials to determine if specialized treatments for GI disorders are necessary in this unique pediatric population, this article reviews the currently available published information.
Included in
Digestive System Diseases Commons, Gastroenterology Commons, Mental Disorders Commons, Other Pharmacy and Pharmaceutical Sciences Commons, Psychiatric and Mental Health Commons, Therapeutics Commons